5-MAPDB
Systematic (IUPAC) name | |
---|---|
1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1354631-78-9 |
ChemSpider | 26679339 |
Chemical data | |
Formula | C12H17NO |
Molecular mass | 191.27 |
|
|
|
5-MAPDB (1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine) is a chemical compound which might be an entactogenic drug. It is structurally related to drugs like 5-APDB and 5-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 5-MAPDB has been studied to determine its pharmacological activity, and was found to be a relatively selective serotonin releaser, though with weaker actions as a releaser of other monoamines and 5-HT2 receptor family agonist,[1] similar to older compounds such as 5-APDB.[2]
Legality
5-MAPDB was banned in the UK in June 2013 as a temporary class drug along with 9 other related compounds, despite having never been sold as a street drug itself. This was due to concerns that it would have similar effects to drugs such as 5-APB that had been widely sold already, and 5-MAPDB might therefore be likely to become used recreationally also, if it were not banned preemptively.[3]
See also
References
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Methamphetamines
- Benzofurans
- Designer drugs